Literature DB >> 6148822

Streptococcus faecium M 74 in control of diarrhoea induced by a human enterotoxigenic Escherichia coli strain in an infant rabbit model.

T Wadström.   

Abstract

Streptococcus faecium strain M 74 was evaluated as a prophylacticum for enterotoxigenic Escherichia coli (ETEC) diarrhoea with human isolates of E. coli with CFA/I and CFA/II surface fimbrial haemagglutinins (adhesins) in a rabbit model. Young rabbits (3 to 4 days old) were given S. faecium organisms (5 X 10(9)) 15 min before (group A), 6 h before (group B) and 12 h after (group C) challenge with ETEC organisms. Only 4 out of 26 rabbits in group A, 6 out of 21 in group B and 7 out of 23 in group C developed diarrhoea. In conclusion, this S. faecium strain M 74 seems efficiently to protect animals from ETEC diarrhoea when given as a prophylactic agent at a high dose. This animal model seems useful for comparative studies on new preventive methods for ETEC diarrhoea such as testing probiotics and antiadhesive drugs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148822

Source DB:  PubMed          Journal:  Zentralbl Bakteriol Mikrobiol Hyg A        ISSN: 0176-6724


  4 in total

1.  Anti-mutagenic and immuno-stimulatory properties of lactic acid bacteria.

Authors:  L Ebringer; M Ferenčík; N Lahitová; L Kačáni; D Michálková
Journal:  World J Microbiol Biotechnol       Date:  1995-05       Impact factor: 3.312

2.  Maternal vaccination with a fimbrial tip adhesin and passive protection of neonatal mice against lethal human enterotoxigenic Escherichia coli challenge.

Authors:  Wilson B Luiz; Juliana F Rodrigues; Joseph H Crabb; Stephen J Savarino; Luis C S Ferreira
Journal:  Infect Immun       Date:  2015-09-14       Impact factor: 3.441

3.  Reduction of Salmonella in gnotobiotic Japanese quails caused by the enterocin A-producing EK13 strain of Enterococcus faecium.

Authors:  A Lauková; P Guba; R Nemcová; Z Vasilková
Journal:  Vet Res Commun       Date:  2003-05       Impact factor: 2.459

4.  Bowel flora changes in humans receiving cefixime (CL 284,635) or cefaclor.

Authors:  S M Finegold; L Ingram-Drake; R Gee; J Reinhardt; M A Edelstein; K MacDonald; H Wexler
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.